These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 27121087)
1. Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen. Real CI; Lu M; Liu J; Huang X; Trippler M; Hossbach M; Deckert J; Jahn-Hofmann K; Ickenstein LM; John MJ; Gibbert K; Dittmer U; Vornlocher HP; Schirmbeck R; Gerken G; Schlaak JF; Broering R Sci Rep; 2016 Apr; 6():24865. PubMed ID: 27121087 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219 [TBL] [Abstract][Full Text] [Related]
3. Poly(I:C) Induces Distinct Liver Cell Type-Specific Responses in Hepatitis B Virus-Transgenic Mice In Vitro, but Fails to Induce These Signals In Vivo. Schefczyk S; Luo X; Liang Y; Trippler M; Lu M; Wedemeyer H; Schmidt HH; Broering R Viruses; 2023 May; 15(5):. PubMed ID: 37243287 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296 [TBL] [Abstract][Full Text] [Related]
5. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model. Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792 [TBL] [Abstract][Full Text] [Related]
6. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri. Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415 [TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen. Jiang M; Broering R; Trippler M; Poggenpohl L; Fiedler M; Gerken G; Lu M; Schlaak JF J Viral Hepat; 2014 Dec; 21(12):860-72. PubMed ID: 24498958 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism. van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316 [TBL] [Abstract][Full Text] [Related]
10. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice. Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914 [TBL] [Abstract][Full Text] [Related]
11. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection. Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C Front Immunol; 2019; 10():112. PubMed ID: 30778353 [No Abstract] [Full Text] [Related]
12. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver. Suslov A; Boldanova T; Wang X; Wieland S; Heim MH Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639 [TBL] [Abstract][Full Text] [Related]
13. Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients. Wiegand SB; Jaroszewicz J; Potthoff A; Höner Zu Siederdissen C; Maasoumy B; Deterding K; Manns MP; Wedemeyer H; Cornberg M Clin Microbiol Infect; 2015 Jul; 21(7):710.e1-9. PubMed ID: 25882360 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Zhang E; Lu M Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115 [TBL] [Abstract][Full Text] [Related]
15. Early inhibition of hepatocyte innate responses by hepatitis B virus. Luangsay S; Gruffaz M; Isorce N; Testoni B; Michelet M; Faure-Dupuy S; Maadadi S; Ait-Goughoulte M; Parent R; Rivoire M; Javanbakht H; Lucifora J; Durantel D; Zoulim F J Hepatol; 2015 Dec; 63(6):1314-22. PubMed ID: 26216533 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Salpini R; Colagrossi L; Bellocchi MC; Surdo M; Becker C; Alteri C; Aragri M; Ricciardi A; Armenia D; Pollicita M; Di Santo F; Carioti L; Louzoun Y; Mastroianni CM; Lichtner M; Paoloni M; Esposito M; D'Amore C; Marrone A; Marignani M; Sarrecchia C; Sarmati L; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V Hepatology; 2015 Mar; 61(3):823-33. PubMed ID: 25418031 [TBL] [Abstract][Full Text] [Related]
17. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication. Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro. Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance. Lan P; Zhang C; Han Q; Zhang J; Tian Z Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417 [TBL] [Abstract][Full Text] [Related]
20. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. Ma Z; Zhang E; Yang D; Lu M Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]